X4 Pharmaceuticals Inc

NASDAQ:XFOR 4:00:00 PM EDT

0.51

-0.01 (-2.33%)

6:51:36 PM EDT: $0.50 -0.01 (-2.29%)

Market Cap (Intraday)	84.21M
Current PE	4.78
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.69 Million
Adjusted EPS	-$0.17

See more estimates

10-Day MA	$0.57
50-Day MA	$0.66
200-Day MA	$0.89

See more pivots

X4 Pharmaceuticals Inc Stock, NASDAQ:XFOR

61 North Beacon Street, 4th floor, Boston, Massachusetts 02134

United States of America

Phone: +1.857.529.8300

Number of Employees: 93

http://www.x4pharma.com

Description

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.